Methods are provided for treating arrhythmia in a manner that minimizes undesirable
side effects, comprising administration of a therapeutically effective minimal
dose of an A1 adenosine receptor agonist with a therapeutically effective
minimal dose of a beta blocker, calcium channel blocker, or a cardiac glycoside.
